Safety and immunogenicity of candidate vaccine M72/AS01(E) in adolescents in a TB endemic setting

Lignende værker

• A Randomized, Controlled Safety, and Immunogenicity Trial of the M72/AS01 Candidate Tuberculosis Vaccine in HIV-Positive Indian Adults
  af: Kumarasamy, Nagalingeswaran, et al.
  Udgivet: (2016)
• Long-term safety and immunogenicity of the M72/AS01(E) candidate tuberculosis vaccine in HIV-positive and -negative Indian adults: Results from a phase II randomized controlled trial
  af: Kumarasamy, Nagalingeswaran, et al.
  Udgivet: (2018)
• Induction and Regulation of T-Cell Immunity by the Novel Tuberculosis Vaccine M72/AS01 in South African Adults
  af: Day, Cheryl L., et al.
  Udgivet: (2013)
• A Randomized, Controlled Dose-Finding Phase II Study of the M72/AS01 Candidate Tuberculosis Vaccine in Healthy PPD-Positive Adults
  af: Montoya, Jaime, et al.
  Udgivet: (2013)
• Evaluation of the immune response to RTS,S/AS01 and RTS,S/AS02 adjuvanted vaccines: Randomized, double-blind study in malaria-naïve adults
  af: Leroux-Roels, Geert, et al.
  Udgivet: (2014)